Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647568 · ClinicalTrials.gov registry record
Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study
A clinical trial, sponsored by Dallas VA Medical Center.
- Completed
- Registry status
- 715
- Enrollment target
NCT01647568: Completed study, sponsored by Dallas VA Medical Center.
NCT01647568 is a clinical trial that has completed, run by Dallas VA Medical Center. The registered enrollment target is 715 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01647568 has completed, sponsored by Dallas VA Medical Center.
- COMPLETED
- Registry status
- 715 participants
- Enrollment target
Study Summary
At our VA hospital, in general, it is the policy of our GI lab to not stop our patients anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we believe the risk of stopping these sort of medications outweigh the risks of a complication from a colonoscopy. Therefore, we are enrolling patients who are either on clopidogrel or prasugrel or not on any anti-platelet/anti-coagulant therapy that come to our GI lab routine colonoscopies. We perform the procedure just like we normally would and then follow-up with the patient 7 and 30 days after their procedure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2009-12 |
What the finished NCT01647568 record still lists
NCT01647568 is an observational study that tracks outcomes without assigning an intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01647568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01647568 about?
NCT01647568 is a clinical study titled "Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study". At our VA hospital, in general, it is the policy of our GI lab to not stop our patients anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we believe the risk of stopping these sort of medications outweigh the risks of a complication from a colonoscopy. Therefo...
What is the current status of trial NCT01647568?
This trial is currently completed. The enrollment target is 715 participants. The study started on 2009-12.
Who is sponsoring clinical trial NCT01647568?
This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia